Achieving consensus regarding the current treatment options for CPA

C. Godet (Poitiers, France)

Source: International Congress 2018 – Chronic pulmonary aspergillosis: from guidelines to real-life implementation

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Godet (Poitiers, France). Achieving consensus regarding the current treatment options for CPA. International Congress 2018 – Chronic pulmonary aspergillosis: from guidelines to real-life implementation

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Treatment options and recommendations
Source: International Congress 2019 – European guidelines for malignant pleural mesothelioma management in 2019
Year: 2019


Treatment options and recommendations
Source: Virtual Congress 2021 – ERS clinical practice guidelines on treatment of sarcoidosis
Year: 2021


Treatment options and recommendations
Source: Virtual Congress 2021 – ERS Clinical practice guidelines for managing children and adolescents with bronchiectasis
Year: 2021


Treatment options and recommendations
Source: Virtual Congress 2021 – ERS guidelines on non-continuous positive airway pressure therapies in obstructive sleep apnoea
Year: 2021


ERS guidelines: treatment options and recommendations
Source: International Congress 2019 – Guidelines for long-term non-invasive ventilation in chronic obstructive pulmonary disease
Year: 2019


Current approaches to formulate evidence-based recommendations: a case study of WHO drug-resistant tuberculosis treatment guidance
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018



A new definition of multimodality treatment
Source: International Congress 2016 – Oligometastasis: postmodern multimodality concepts
Year: 2016


Other options of prevention - the current state and the future
Source: Annual Congress 2003 - Latent tuberculosis infection - preventive approaches
Year: 2003

Pharmacological options for the treatment of COPD: present and future
Source: Annual Congress 2007 - PG6 - COPD: comprehensive clinical assessment and pharmacological and nonpharmacological therapy
Year: 2007

Therapeutic strategies: what treatment for what patient
Source: Annual Congress 2008 - PG12 - Challenges in pulmonary embolism: hot issues and interactive cases (jointly organised with ACCP)
Year: 2008



From staging to therapy: implications of the new staging system with a focus on multi-modal treatment options
Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy
Year: 2017


What is the difference between an evidence-based guideline and a consensus statement?
Source: Annual Congress 2006 - PG16 - The use of evidence-based medicine and practice for the clinician (jointly organised with the ACCP)
Year: 2006



Overall treatment strategies
Source: Eur Respir Monogr 2015; 67: 305-325
Year: 2015